BILL · 2021–22 SESSION · LATEST VERSION SSB 5723

SB 5723: Diversity in clinical trials

Concerning improving diversity in clinical trials.

Summary

  • Directs the Washington State Review Board to establish a program to encourage diversity in clinical trials for drugs and medical devices for underrepresented demographic groups.
  • Requires state entities conducting clinical trials of drugs or medical devices to adopt policies for identifying and recruiting members of underrepresented demographic groups to participate in clinical trials.

From the Substitute House Bill Report (SSB 5723), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · passed Senate, stalled in House
  1. IntroducedJan 10, 2022
  2. Out of committeeFeb 7, 2022
  3. Passed SenateFeb 14, 2022
  4. Passed Housestopped here
  5. Governor
  6. Law
Prime sponsor
Senator (R-18)
Introduced
January 10, 2022 in the Senate
Last action
March 10, 2022
Budget
Has a fiscal note
Versions
SB 5723, SSB 5723

AN ACT Relating to improving diversity in clinical trials;

Sponsors

Prime sponsor: Senator (R-18)

2 co-sponsors (2 Democrats, 0 Republicans)

Votes

Senate · 3rd Reading & Final Passage

Passed February 14, 2022
Version voted on: SSB 5723
48 Yea 0 Nay 0 Absent 1 Excused
PartyYeaNayAbsentExcused
Democrat28001
Republican20000
How each member voted

History

  1. By resolution, returned to Senate Rules Committee for third reading. (SSB 5723)
  2. Referred to Appropriations. (SSB 5723)
  3. HCW - Majority; do pass. (SSB 5723)
  4. HCW - Executive action taken by committee. (SSB 5723)
  5. First reading, referred to Health Care & Wellness. (SSB 5723)
  6. Third reading, passed; yeas, 48; nays, 0; absent, 0; excused, 1. (SSB 5723)
  7. Rules suspended. Placed on Third Reading. (SSB 5723)
  8. 1st substitute bill substituted. (SSB 5723)
  9. 1st substitute bill substituted.
  10. Placed on second reading by Rules Committee. (SSB 5723)
  11. Placed on second reading by Rules Committee.
  12. Passed to Rules Committee for second reading. (SSB 5723)
  13. Minority; without recommendation. (SSB 5723)
  14. WM - Majority; do pass 1st substitute bill proposed by Health & Long Term Care. (SSB 5723)
  15. WM - Majority; do pass 1st substitute bill proposed by Health & Long Term Care.
  16. Minority; without recommendation.
  17. Passed to Rules Committee for second reading.
  18. Referred to Ways & Means. (SSB 5723)
  19. Referred to Ways & Means.
  20. HLTC - Majority; 1st substitute bill be substituted, do pass. (SSB 5723)
  21. Minority; do not pass. (SSB 5723)
  22. And refer to Ways & Means. (SSB 5723)
  23. Minority; without recommendation. (SSB 5723)
  24. Minority; without recommendation.
  25. And refer to Ways & Means.
  26. Minority; do not pass.
  27. HLTC - Majority; 1st substitute bill be substituted, do pass.
  28. First reading, referred to Health & Long Term Care.
  29. Prefiled for introduction.

SB 5723 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page